KURT KROUSE: Open Payments
NPI 1689826323 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,426 in 53 payments from 15 companies in 2025. Trend: 2023 $324 · 2024 $492 · 2025 $1,426
Food & beverage: $1,326Education: $100
| Company | Payments | Amount |
|---|---|---|
| JAZZ PHARMACEUTICALS INC. | 10 | $497 |
| Lilly USA, LLC | 4 | $154 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $149 |
| Verona Pharma, Inc. | 7 | $139 |
| HARMONY BIOSCIENCES LLC | 4 | $94 |
| AstraZeneca Pharmaceuticals LP | 5 | $76 |
| GlaxoSmithKline, LLC. | 3 | $57 |
| Regeneron Healthcare Solutions, Inc. | 3 | $54 |
| Grifols USA, LLC | 2 | $49 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $48 |
Products named: XYWAV, ZEPBOUND, Ohtuvayre, WAKIX, JASCAYD, DUPIXENT, Prolastin-C Liquid, TRELEGY ELLIPTA.
Industry payments across KY — which companies pay providers there.
